Financials Krsnaa Diagnostics Limited Bombay S.E.

Equities

KRSNAA

INE08LI01020

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:00:52 2024-07-16 am EDT 5-day change 1st Jan Change
670.4 INR +1.32% Intraday chart for Krsnaa Diagnostics Limited -2.52% -4.95%

Valuation

Fiscal Period: March 2022 2023 2024 2025 2026
Capitalization 1 15,344 14,449 21,658 - -
Enterprise Value (EV) 1 15,344 14,449 19,845 21,658 21,658
P/E ratio 21.4 x 23.3 x 34.3 x 25.1 x 15.6 x
Yield - - 0.41% 0.45% 0.75%
Capitalization / Revenue 3.37 x 2.97 x 3.2 x 2.67 x 1.99 x
EV / Revenue 3.37 x 2.97 x 3.2 x 2.67 x 1.99 x
EV / EBITDA 11.7 x 11.8 x 13.8 x 10.5 x 7.6 x
EV / FCF -404 x -22.2 x -11.7 x 34.5 x 305 x
FCF Yield -0.25% -4.5% -8.54% 2.89% 0.33%
Price to Book 2.13 x 1.96 x 2.45 x 2.42 x 2.1 x
Nbr of stocks (in thousands) 31,398 31,398 32,290 - -
Reference price 2 488.7 460.2 670.8 670.8 670.8
Announcement Date 5/28/22 5/27/23 5/18/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net sales 1 - 4,554 4,871 6,196 8,111 10,899
EBITDA 1 - 1,315 1,223 1,442 2,061 2,851
EBIT 1 - 900.9 685.2 697 1,182 1,818
Operating Margin - 19.78% 14.07% 11.25% 14.58% 16.68%
Earnings before Tax (EBT) 1 - 865.1 802 700.1 1,110 1,796
Net income 1 1,849 683.9 621.1 568.4 855.3 1,374
Net margin - 15.02% 12.75% 9.17% 10.54% 12.61%
EPS 2 - 22.88 19.78 17.90 26.73 43.00
Free Cash Flow 1 - -37.95 -650.6 -1,695 627 71
FCF margin - -0.83% -13.36% -27.36% 7.73% 0.65%
FCF Conversion (EBITDA) - - - - 30.43% 2.49%
FCF Conversion (Net income) - - - - 73.3% 5.17%
Dividend per Share 2 - - - 2.500 3.000 5.000
Announcement Date 8/3/21 5/28/22 5/27/23 5/18/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 - 1,226 1,332 1,396 1,608 1,550 1,650 1,764
EBITDA 1 - 294.1 344.8 313.6 403 348 403 452.5
EBIT - - - - - 186 226 217
Operating Margin - - - - - 12% 13.7% 12.3%
Earnings before Tax (EBT) - - - - - - - -
Net income 1 153.4 136.4 189.2 146.4 203.5 146 153.5 174
Net margin - 11.12% 14.2% 10.49% 12.66% 9.42% 9.31% 9.86%
EPS - - - - 7.400 5.350 5.000 5.500
Dividend per Share - - - - - - - -
Announcement Date 11/9/22 2/13/23 5/27/23 8/12/23 - - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - -38 -651 -1,695 627 71
ROE (net income / shareholders' equity) - 14.9% 8.73% 7.34% 10.2% 14.2%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - 229.0 235.0 251.0 277.0 319.0
Cash Flow per Share - - - - - -
Capex 1 - 1,322 1,414 1,939 1,551 1,875
Capex / Sales - 29.03% 29.02% 31.29% 19.12% 17.2%
Announcement Date 8/3/21 5/28/22 5/27/23 5/18/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
670.8 INR
Average target price
927 INR
Spread / Average Target
+38.20%
Consensus
  1. Stock Market
  2. Equities
  3. KRSNAA Stock
  4. KRSNAA Stock
  5. Financials Krsnaa Diagnostics Limited